Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Ventricular Mass as a Prognostic Imaging Biomarker in Incident PAH.

Simpson CE, Damico RL, Kolb TM, Mathai SC, Khair RM, Sato T, Bourji K, Tedford RJ, Zimmerman SL, Hassoun PM.

Eur Respir J. 2019 Jan 31. pii: 1802067. doi: 10.1183/13993003.02067-2018. [Epub ahead of print] No abstract available.

PMID:
30705128
2.

Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers.

Furfaro D, Azadi J, Housten T, Kolb TM, Damico RL, Hassoun PM, Chin K, Mathai SC.

Ann Am Thorac Soc. 2019 Feb;16(2):277-280. doi: 10.1513/AnnalsATS.201809-588RL. No abstract available.

PMID:
30359536
3.

Focused Review of Perioperative Care of Patients with Pulmonary Hypertension and Proposal of a Perioperative Pathway.

Steppan J, Diaz-Rodriguez N, Barodka VM, Nyhan D, Pullins E, Housten T, Damico RL, Mathai SC, Hassoun PM, Berkowitz DE, Maxwell BG, Kolb TM.

Cureus. 2018 Jan 15;10(1):e2072. doi: 10.7759/cureus.2072. Review.

4.

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.

Hsu S, Kokkonen-Simon KM, Kirk JA, Kolb TM, Damico RL, Mathai SC, Mukherjee M, Shah AA, Wigley FM, Margulies KB, Hassoun PM, Halushka MK, Tedford RJ, Kass DA.

Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.

PMID:
29352073
5.

Imatinib Is Protective Against Ischemia-Reperfusion Injury in an Ex Vivo Rabbit Model of Lung Injury.

Magruder JT, Grimm JC, Crawford TC, Johnston L, Santhanam L, Stephens RS, Berkowitz DE, Shah AS, Bush EL, Damarla M, Damico RL, Hassoun PM, Kim BS.

Ann Thorac Surg. 2018 Mar;105(3):950-956. doi: 10.1016/j.athoracsur.2017.10.002. Epub 2017 Dec 28.

PMID:
29289364
6.

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

Sato T, Ambale-Venkatesh B, Lima JAC, Zimmerman SL, Tedford RJ, Fujii T, Hulme OL, Pullins EH, Corona-Villalobos CP, Zamanian RT, Minai OA, Girgis RE, Chin K, Khair R, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217748307. doi: 10.1177/2045893217748307. Epub 2017 Dec 18.

PMID:
29251556
7.

Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.

Mullin CJ, Hsu S, Amancherla K, Wand A, Rhodes P, Leary PJ, Mukherjee M, Damico RL, Kolb TM, Mathai SC, Hassoun PM, Tedford RJ.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700784. doi: 10.1183/13993003.00784-2017. Print 2017 Sep. No abstract available.

8.

XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.

Damarla M, Johnston LF, Liu G, Gao L, Wang L, Varela L, Kolb TM, Kim BS, Damico RL, Hassoun PM.

Physiol Rep. 2017 Aug;5(15). pii: e13377. doi: 10.14814/phy2.13377.

9.

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction.

Bourji KI, Kelemen BW, Mathai SC, Damico RL, Kolb TM, Mercurio V, Cozzi F, Tedford RJ, Hassoun PM.

Pulm Circ. 2017 Apr-Jun;7(2):409-420. doi: 10.1177/2045893217700438. Epub 2017 Mar 27.

10.

Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.

Wu D, Talbot CC Jr, Liu Q, Jing ZC, Damico RL, Tuder R, Barnes KC, Hassoun PM, Gao L.

J Mol Med (Berl). 2016 Aug;94(8):875-85. doi: 10.1007/s00109-016-1426-z. Epub 2016 May 18.

11.

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Hsu S, Houston BA, Tampakakis E, Bacher AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA, McMahan Z, Corona-Villalobos CP, Zimmerman SL, Wigley FM, Hassoun PM, Kass DA, Tedford RJ.

Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.

12.

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.

Khair RM, Nwaneri C, Damico RL, Kolb T, Hassoun PM, Mathai SC.

Ann Am Thorac Soc. 2016 Jun;13(6):842-9. doi: 10.1513/AnnalsATS.201512-824OC.

13.

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM.

Ann Am Thorac Soc. 2016 Jan;13(1):31-9. doi: 10.1513/AnnalsATS.201412-572OC.

14.

Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia-Induced Pulmonary Hypertension.

Kolb TM, Peabody J, Baddoura P, Fallica J, Mock JR, Singer BD, D'Alessio FR, Damarla M, Damico RL, Hassoun PM.

Microcirculation. 2015 Nov;22(8):724-36. doi: 10.1111/micc.12247.

15.

Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Kelemen BW, Mathai SC, Tedford RJ, Damico RL, Corona-Villalobos C, Kolb TM, Chaisson NF, Harris TH, Zimmerman SL, Kamel IR, Kass DA, Hassoun PM.

Pulm Circ. 2015 Jun;5(2):327-34. doi: 10.1086/680356.

16.

Vascular receptor autoantibodies in pulmonary arterial hypertension.

Bourji KI, Khair RM, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):602. doi: 10.1164/rccm.201412-2267LE. No abstract available.

PMID:
25723828
17.

Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3.

Damarla M, Parniani AR, Johnston L, Maredia H, Serebreni L, Hamdan O, Sidhaye VK, Shimoda LA, Myers AC, Crow MT, Schmidt EP, Machamer CE, Gaestel M, Rane MJ, Kolb TM, Kim BS, Damico RL, Hassoun PM.

Am J Respir Cell Mol Biol. 2014 May;50(5):932-41. doi: 10.1165/rcmb.2013-0361OC.

18.

Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension.

Kolb TM, Damico RL, Hassoun PM.

J Mol Med (Berl). 2011 Aug;89(8):729-32. doi: 10.1007/s00109-011-0783-x. No abstract available.

PMID:
21735043
19.

Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis.

Damico RL, Chesley A, Johnston L, Bind EP, Amaro E, Nijmeh J, Karakas B, Welsh L, Pearse DB, Garcia JG, Crow MT.

Am J Respir Cell Mol Biol. 2008 Jul;39(1):77-85. doi: 10.1165/rcmb.2007-0248OC. Epub 2008 Jan 31.

20.

Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.

Wadgaonkar R, Pierce JW, Somnay K, Damico RL, Crow MT, Collins T, Garcia JG.

Am J Respir Cell Mol Biol. 2004 Oct;31(4):423-31. Epub 2004 Jul 1.

PMID:
15231489
21.

Receptor-triggered membrane association of a model retroviral glycoprotein.

Damico RL, Crane J, Bates P.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5.

22.

Human neonatal thymic organ culture: an ex vivo model of thymocyte ontogeny and HIV-1 infection.

Rosenzweig M, Bunting EM, Damico RL, Clark DP, Gaulton GN.

Pathobiology. 1994;62(5-6):245-51.

PMID:
7598793

Supplemental Content

Loading ...
Support Center